Human tumour-induced inhibition of interferon action in vitro: reversal of inhibition by beta-carotene (pro-vitamin A)

Cancer Immunol Immunother. 1984;16(3):189-92. doi: 10.1007/BF00205428.

Abstract

Inhibitors of human interferon action that might be relevant to tumour resistance or escape mechanisms were investigated in a macrophage system. The effects of IFN on macrophage Fc gamma receptor expression were inhibited by three preparations: (1) a low-molecular-weight component of normal autologous serum; (2) a low-molecular-weight component of carcinoma supernatant; and (3) physiological concentrations of retinol and retinoic acid. Since human carcinoma tissue contains abnormally high levels of retinoic acid-binding protein, the possibility that a tumour-associated retinoid contributes to tumour-induced inhibition in vitro was investigated. Inhibition of IFN action in vitro by retinoic acid (vitamin A acid) was found to be reversed by beta-carotene (pro-vitamin A). When tested in the tumour system beta-carotene also reversed inhibition by the human-carcinoma-derived signal. These data are consistent with the view that at least one of the tumour-derived signals inhibitory towards IFN is a tumour-associated retinoid, although firm evidence for this must await further physicochemical characterization of the inhibitory signal(s). The present data clearly show, nevertheless, that human tumour-induced inhibition of IFN in vitro can be reversed by the pro-vitamin beta-carotene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carotenoids / pharmacology*
  • Humans
  • Interferon Type I / antagonists & inhibitors*
  • Macrophages / immunology
  • Receptors, Fc / drug effects
  • Urinary Bladder Neoplasms / immunology*
  • beta Carotene

Substances

  • Interferon Type I
  • Receptors, Fc
  • beta Carotene
  • Carotenoids